Yale Jen analyst LAIDLAW

Currently out of the existing stock ratings of Yale Jen, 15 are a BUY (100%).

Yale Jen

Work Performance Price Targets & Ratings Chart

Analyst Yale Jen works at LAIDLAW with a stock forecast success ratio of 47% fulfilled within 155 days on average.

Yale Jen’s has documented 30 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SLNO, Soleno Therapeutics at 27-Sep-2023.

Wall Street Analyst Yale Jen

Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $10 was fulfilled within 31 days with a profit of $3.45 (52.67%) receiving and performance score of 16.99.

Average potential price target upside

ARCT Arcturus Therapeutics Holdings CRIS Curis VINC Vincerx Pharma IONS Ionis Pharmaceuticals EVFM Evofem Biosciences TCRT Alaunos Therapeutics SLNO Soleno Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

86

$55.59 (182.80%)

87

16 days ago

1/3 (33.33%)

$58.74 (215.48%)

75

Buy

48

$17.59 (57.84%)

40

3 months 18 days ago

4/8 (50%)

$10.09 (26.62%)

195

Buy

51

$20.59 (67.71%)

51

5 months 28 days ago

14/24 (58.33%)

$25.48 (99.84%)

165

Buy

54

$23.59 (77.57%)

54

9 months 4 days ago

2/5 (40%)

$21.39 (65.59%)

548

Buy

36

10 months 12 days ago

2/2 (100%)

$15.83 (78.48%)

271

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Yale Jen?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?